From the Department of Pediatrics, Faculty of Medicine and Dentistry, Cardiovascular Research Centre, Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Alberta, Canada (B.N.M.Z., J.N., T.P., P.C.K., G.M., T.J.W., J.R.B.D.); Department of Medicine, St. Vincent's Institute of Medical Research, University of Melbourne, Melbourne, Victoria, Australia (B.E.K.); and Division of Endocrinology and Metabolism, Department of Medicine and Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada (G.R.S.).
Circ Res. 2014 Aug 15;115(5):518-24. doi: 10.1161/CIRCRESAHA.115.304538. Epub 2014 Jul 7.
RATIONALE: The energy sensor AMP-activated protein kinases (AMPK) is thought to play an important role in regulating myocardial fatty acid oxidation (FAO) via its phosphorylation and inactivation of acetyl coenzyme A carboxylase (ACC). However, studies supporting this have not directly assessed whether the maintenance of FAO rates and subsequent cardiac function requires AMPK-dependent inhibitory phosphorylation of ACC. OBJECTIVE: To determine whether preventing AMPK-mediated inactivation of ACC influences myocardial FAO or function. METHODS AND RESULTS: A double knock-in (DKI) mouse (ACC-DKI) model was generated in which the AMPK phosphorylation sites Ser79 on ACC1 and Ser221 (Ser212 mouse) on ACC2 were mutated to prevent AMPK-dependent inhibitory phosphorylation of ACC. Hearts from ACC-DKI mice displayed a complete loss of ACC phosphorylation at the AMPK phosphorylation sites. Despite the inability of AMPK to regulate ACC activity, hearts from ACC-DKI mice displayed normal basal AMPK activation and cardiac function at both standard and elevated workloads. In agreement with the inability of AMPK in hearts from ACC-DKI mice to phosphorylate and inhibit ACC, there was a significant increase in cardiac malonyl-CoA content compared with wild-type mice. However, cardiac FAO rates were comparable between wild-type and ACC-DKI mice at baseline, during elevated workloads, and after a more stressful condition of myocardial ischemia that is known to robustly activate AMPK. CONCLUSIONS: Our findings show AMPK-dependent inactivation of ACC is not essential for the control of myocardial FAO and subsequent cardiac function during a variety of conditions involving AMPK-independent and AMPK-dependent metabolic adaptations.
原理:能量传感器 AMP 激活的蛋白激酶(AMPK)被认为通过其磷酸化和乙酰辅酶 A 羧化酶(ACC)的失活在调节心肌脂肪酸氧化(FAO)中发挥重要作用。然而,支持这一观点的研究尚未直接评估维持 FAO 速率和随后的心脏功能是否需要 AMPK 依赖性抑制性 ACC 磷酸化。
目的:确定是否防止 AMPK 介导的 ACC 失活会影响心肌 FAO 或功能。
方法和结果:生成了双重敲入(DKI)小鼠(ACC-DKI)模型,其中 ACC1 的 AMPK 磷酸化位点 Ser79 和 ACC2 的 Ser212(Ser221 小鼠)被突变为防止 AMPK 依赖性抑制性 ACC 磷酸化。ACC-DKI 小鼠的心脏显示出 ACC 在 AMPK 磷酸化位点的完全磷酸化缺失。尽管 AMPK 无法调节 ACC 活性,但 ACC-DKI 小鼠的心脏在标准和升高的工作量下均显示出正常的基础 AMPK 激活和心脏功能。与 ACC-DKI 小鼠的心脏中 AMPK 无法磷酸化和抑制 ACC 一致,与野生型小鼠相比,心脏中的丙二酰辅酶 A 含量显着增加。然而,在基线、升高的工作量以及已知强烈激活 AMPK 的心肌缺血更具应激条件下,野生型和 ACC-DKI 小鼠的心脏 FAO 率相当。
结论:我们的研究结果表明,ACC 的 AMPK 依赖性失活对于控制各种涉及 AMPK 非依赖性和 AMPK 依赖性代谢适应的条件下的心肌 FAO 和随后的心脏功能不是必需的。
J Physiol. 2008-12-1
Am J Physiol Endocrinol Metab. 2007-12
Theranostics. 2025-1-1
Int J Mol Sci. 2024-11-28
Dis Model Mech. 2024-8-1
Cardiovasc Res. 2023-11-25
Bioeng Transl Med. 2023-4-6
Am J Respir Cell Mol Biol. 2023-1